COMPANIES COVERED
F. Hoffmann-La RocheDownload FREE Report Sample
Download Free sampleAntiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones
Anti-Viral Drugs Market contains market size and forecasts of Anti-Viral Drugs in global, including the following market information:
Global Anti-Viral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-Viral Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-Viral Drugs companies in 2021 (%)
The global Anti-Viral Drugs market was valued at 121020 million in 2021 and is projected to reach US$ 152400 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nucleotide Polymerase Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Viral Drugs include F. Hoffmann-La Roche, GlaxoSmithKline, Bristol-Myers-Squibb, AbbVie, Johnson & Johnson, Merck & Co, Aurobindo Pharma, Cipla and Dr Reddy?s. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Viral Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Viral Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Viral Drugs Market Segment Percentages, by Type, 2021 (%)
Nucleotide Polymerase Inhibitor
Reverse Transcriptase Inhibitor
Protease Inhibitor
Global Anti-Viral Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Viral Drugs Market Segment Percentages, by Application, 2021 (%)
HIV
Hepatitis
HSV
Influenza
Global Anti-Viral Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Viral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Viral Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-Viral Drugs revenues share in global market, 2021 (%)
Key companies Anti-Viral Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anti-Viral Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche
GlaxoSmithKline
Bristol-Myers-Squibb
AbbVie
Johnson & Johnson
Merck & Co
Aurobindo Pharma
Cipla
Dr Reddy?s
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
